Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Mar 9, 2018 · 10-K · 68 days after period end · 0001140361-18-012817
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Net Income | -$3.59M | -$525.48K | -$2.85M | -$2.21M |
| EPS Diluted | -$0.12 | -$0.02 | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 9, 2018 · 68 d after period end
